Obstructive sleep apnea (OSA) is a chronic condition, and management requires life-long adherence to therapy. Continuous Positive Airway Pressure (CPAP) and Mandibular Advancement Splints (MAS) are disease-specific therapies for OSA, with CPAP being the first-line treatment. The current literature lacks information regarding their comparative effectiveness based on an objective assessment of adherence. Additionally, the effect of combining the two therapies has not been previously investigated. This presentation will answer the following questions: How does the effectiveness of MAS compare to that of CPAP? How does the combination of both therapies compare to having only one therapy in terms of adherence, quality of life and overall effectiveness?
Identify the effect of adherence on long term effectiveness.
Recognize treatment usage patterns when patients have access to both therapies.
Assess the effect of CPAP, MAS and the combination of both therapies on multiple treatment outcomes.